Tatva Chintan Pharma Chem Limited (NSE:TATVA)
India · Delayed Price · Currency is INR 1,216.60
+31.90 (2.69%)
Feb 17, 2026, 2:20 PM IST
Tatva Chintan Pharma Chem Market Cap
Tatva Chintan Pharma Chem has a market cap or net worth of 27.71 billion as of February 13, 2026. Its market cap has increased by 46.62% in one year.
Market Cap
27.71B
Enterprise Value
28.37B
Revenue
4.80B
Ranking
n/a
PE Ratio
84.52
Stock Price
1,216.60
Market Cap Chart
Since July 29, 2021, Tatva Chintan Pharma Chem's market cap has decreased from 51.25B to 27.71B, a decrease of -45.93%. That is a compound annual growth rate of -12.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 27.71B | -11.21% |
| Dec 31, 2025 | 31.21B | 49.99% |
| Dec 31, 2024 | 20.81B | -44.47% |
| Dec 29, 2023 | 37.47B | -21.40% |
| Dec 30, 2022 | 47.67B | -19.02% |
| Dec 31, 2021 | 58.86B | 14.86% |
| Jul 29, 2021 | 51.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neogen Chemicals | 36.51B |
| Advanced Enzyme Technologies | 33.68B |
| Rossari Biotech | 29.03B |
| Jubilant Agri and Consumer Products | 28.73B |
| Fineotex Chemical | 28.01B |
| Sirca Paints India | 26.84B |
| NOCIL | 25.27B |
| Veedol Corporation | 24.51B |